FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmic surgery. Vitrectomy is performed, autologous platelet-rich plasma (hereinafter PRP) obtained from the patient's venous blood is injected into the macular rupture area (MRA) in an amount sufficient to close the MRA, and gas tamponade of the vitreous cavity. In this case, after the introduction of PRP into the rupture, the intravitreal fluid released from the MRA and excess PRP are aspirated. After that, the same amount of PRP is reintroduced into the gap.
EFFECT: invention allows increasing efficiency of the operation by achieving a good anatomical effect, as well as reducing the risks of intra- and postoperative complications.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SURGICAL TREATMENT OF MACULAR RUPTURES USING AUTOLOGOUS THROMBOCYTE ENRICHED PLASMA | 2019 |
|
RU2720164C1 |
| METHOD OF PRODUCING PLATELET-RICH BLOOD PLASMA FOR TREATMENT OF MACULAR RETINAL HOLES | 2022 |
|
RU2805814C1 |
| METHOD FOR SURGICAL TREATMENT OF FULL-THICKNESS MACULAR HOLE | 2023 |
|
RU2797540C1 |
| METHOD OF TREATING MACULAR RETINA FRACTURES WITHOUT VITREAL CAVITY TAMPONAGE | 2020 |
|
RU2735465C1 |
| METHOD FOR DETERMINING TYPE OF TAMPONADE OF VITREAL CAVITY WITH PREOPERATIVE USE OF GLOBAL TESTS FOR ASSESSING THE STATE OF HAEMOSTASIS IN SURGICAL TREATMENT OF RETINAL RUPTURES USING PLATELET-RICH BLOOD PLASMA | 2023 |
|
RU2822651C1 |
| METHOD FOR SURGICAL TREATMENT OF PRIMARY THROUGH MACULAR RETINAL RUPTURE | 2021 |
|
RU2784894C1 |
| METHOD FOR DETERMINING THE EXPOSURE TIME OF PLATELET-RICH BLOOD PLASMA TO THE AREA OF RUPTURE IN THE SURGICAL MANAGEMENT OF MACULAR RETINAL RUPTURES WITH THE PREOPERATIVE APPLICATION OF GLOBAL TEST FOR ASSESSING THE STATE OF HAEMOSTASIS | 2023 |
|
RU2822593C1 |
| METHOD OF SURGICAL MANAGEMENT OF MACULAR HOLES USING AUTOLOGOUS PLATELET-RICH PLASMA AND METHOD OF ITS OBTAINING | 2015 |
|
RU2606338C1 |
| METHOD OF SURGICAL TREATMENT OF MACULAR HOLE | 2022 |
|
RU2803007C1 |
| METHOD OF SURGICAL TREATMENT OF END-TO-END IDIOPATHIC MACULAR RUPTURES OF THE RETINA | 2017 |
|
RU2652076C1 |
